Financial Health Assessment: HYDRON INDUSTRIAL LIMITED

Financial Health Score: D-

Explanation: This company is in a state of technical insolvency, with liabilities exceeding assets by nearly £168,000. It is surviving on life support — specifically, creditor forbearance (likely director loans) that keeps the business breathing. While 2024 showed encouraging signs of improvement, the patient has been in critical condition for many years, and one adverse event could prove fatal.

1. Key Vital Signs

Vital Sign Analysis

Heartbeat (Cash Flow): The most encouraging sign in this assessment. Cash has surged from £5,308 to £40,524 — a 664% increase. The patient's cash pulse, which nearly flatlined in 2019 at just £93, is now the strongest it has been in years. This suggests revenue is flowing and being collected.

Blood Pressure (Liquidity): Dangerously low. The current ratio of 0.14:1 means that for every £1 of short-term obligations, the company has only 14p in current assets. A healthy business typically requires 1.5:1 or higher. This company would need approximately £285,416 in additional working capital just to break even on current obligations.

Cholesterol (Debt Burden): The "other creditors" figure of £312,526 represents the dominant blockage in this company's financial arteries. This single category accounts for approximately 85% of all current liabilities. Given the company's structure (three equal shareholders, two of whom are directors), this almost certainly represents director or related-party loans that are keeping the company afloat.

Bone Density (Asset Quality): Of the £200,869 in total assets, £155,331 (77%) is tied up in tangible fixed assets — primarily plant and equipment (£152,065). These are illiquid assets that cannot quickly be converted to cash to pay creditors. The company is asset-heavy but cash-light, with fixed assets that have been depreciating but still represent significant book value.

2. Symptoms Analysis

Chronic Condition: Persistent Insolvency

The financial history reveals a long-term degenerative condition:

The company crossed into negative net assets territory in 2017 and has never recovered. Over eight years, accumulated losses total approximately £167,948 against share capital of just £100.

Symptom: Volatile Cash Position

The cash position has swung dramatically: - 2019: Nearly zero (£93) — the company was on the edge of cessation - 2023: Dropped to £5,308 after being £31,382 in 2022 - 2024: Rebounded to £40,524

This volatility suggests the business may be project-based or contract-dependent, with significant timing differences between receiving payment and paying creditors.

Symptom: Minimal Operational Scale

With an average of only 1 employee during the year, this is essentially an owner-operated business. The directors (Lee James Upton and Bret Gene Upton) are likely the primary workforce, with the third PSC (Ian Peter Robert Seaton) having a significant but perhaps non-operational stake.

Symptom: Director Dependency

The "other creditors" balance of £312,526 — in a company with only £100 in share capital and accumulated losses of £167,948 — strongly suggests that director loans are financing the entire operation. This creates a critical dependency: if the directors withdraw support, the company cannot survive.

3. Diagnosis

Primary Diagnosis: Chronic Technical Insolvency with Recent Stabilisation

This company is technically insolvent — its liabilities exceed its assets by £167,848. In simple terms, if all creditors demanded payment today, the company could not pay them even if it sold every asset at book value.

However, there are important qualifying factors:

1. Director Loan Dependency: The bulk of liabilities appear to be director or related-party loans. These creditors are unlikely to demand immediate repayment as they are the business operators themselves. This is the financial equivalent of being kept alive by a life-support machine controlled by the patient.

2. 2024 Improvement: The company returned to profitability (~£36,144 profit) after a terrible 2023 (~£54,287 loss). This represents a swing of approximately £90,000, suggesting either a significant contract win, operational restructuring, or improved market conditions.

3. Going Concern Viability: The accounts were approved on 13 August 2025 without a going concern qualification, suggesting the directors believe the company can continue trading for at least 12 months. This implicitly means the directors intend to continue supporting the business financially.

Secondary Diagnosis: Severe Working Capital Deficiency

With net current liabilities of £285,416, the company has no buffer against operational disruptions. A single delayed payment or unexpected expense could trigger a cash crisis.

Risk Classification: HIGH RISK

The company remains in a precarious position despite recent improvement. It is: - Unable to pay debts as they fall due from current assets - Dependent on continued director financial support - Operating with minimal workforce and infrastructure - Carrying significant accumulated losses

4. Prognosis

Short-term Outlook (6-12 months): Guarded but Cautiously Optimistic

The 2024 improvement is genuinely encouraging. Cash has strengthened, the company returned to profit, and liabilities have reduced. If this trajectory continues, the company could gradually rebuild equity.

Medium-term Outlook (1-3 years): Conditional

Recovery depends on: - Sustained profitability: The company needs consecutive years of profit to erode the accumulated losses - Director commitment: Continued willingness to leave loans outstanding rather than demanding repayment - No major disruptions: The thin capital structure means any significant setback could be terminal - Working capital management: Improved cash collection and creditor management

Long-term Outlook: Uncertain

At the current rate of improvement (£36,144 annual profit), it would take approximately 4-5 years of sustained profitability just to eliminate the accumulated deficit — assuming no further capital investment is required and all profits are retained.

5. Recommendations

Immediate Actions (Critical)

1. Formalise Director Loan Arrangements: Document all director loans with clear terms, repayment schedules, and subordination agreements. This protects both the directors and provides transparency for any future financing or due diligence.

2. Cash Flow Forecasting: Implement rolling 13-week cash flow forecasts. With volatile cash patterns, this is essential for anticipating and preventing liquidity crises.

3. Creditor Management: Prioritise negotiation of extended payment terms with trade creditors. Given the company's payment history, suppliers may be willing to formalise longer terms if approached proactively.

Medium-term Actions (Important)

4. Working Capital Injection: Consider a formal capital restructuring — either converting director loans to equity (which would improve the balance sheet immediately) or securing a working capital facility. Converting even £100,000 of director loans to equity would reduce net liabilities to approximately £-68,000 and significantly improve the balance sheet presentation.

5. Profit Protection: The 2024 profit must be the beginning of a trend, not an anomaly. Develop a clear budget and monthly variance analysis to ensure profitability is maintained and improved upon.

6. Fixed Asset Review: With £152,065 in plant and equipment, consider whether all assets are being utilised effectively. Any surplus assets should be disposed of to generate cash and reduce carrying costs.

Long-term Actions (Strategic)

7. Capital Structure Repair: Set a target date (e.g., 3-5 years) for returning to positive net assets. This requires a combination of: - Sustained annual profits of £40,000+ - Conversion of director loans to equity - Potential introduction of external investment

8. Business Model Review: With only one employee and significant fixed assets, evaluate whether the current business model is optimal. Could the company generate better returns with different operational arrangements?

9. Contingency Planning: Develop a formal plan for what happens if director support is withdrawn. This should include trigger points for seeking external financing, restructuring, or potentially winding up the business in an orderly manner rather than through insolvency.

Warning Signs to Monitor